Bellerophon Therapeutics
BLPH
#11324
Rank
C$0.21 M
Marketcap
C$0.01720
Share price
-36.84%
Change (1 day)
-79.59%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): C-$1.14

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$1.20. In 2017 the company made an earnings per share (EPS) of C-$29.67 an increase over its 2016 EPS that were of C-$34.40.

EPS history for Bellerophon Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$1.14
2017C-$29.67-13.75%
2016C-$34.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
C$3.88-421.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.02 67.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
C$5.93-592.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
C$1.89-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA